Please login to the form below
Genentech
This page shows the latest Genentech news and features for those working in and with pharma, biotech and healthcare.
Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy
Genentech’s Evrysdi (risdiplam), a treatment for spinal muscular atrophy (SMA), has been given an extended approved by the US Food and Drug Administration (FDA) to include babies under two months ... Levi Garraway, Genentech’s chief medical officer
Latest news
-
Regeneron signs $900m cancer and infectious disease deal with Nykode
The company already has several strategic agreements with Roche’s Genentech and Nektar in cancer vaccines as well as Adaptive on new vaccines against emerging variants of SARS-CoV-02.
-
Roche bets on T-cell therapies with Adaptimmune deal
Genentech signs deal for five ‘off the shelf’ T-cell therapies and a personalised cell therapy platform in a deal potentially worth more than $3bn. ... Adapatimmune has announced a partnership with Roche’s Genentech that will combine their
-
Mixed results for AC Immune's promising Alzheimer’s antibody
Swiss biotech AC Immune and partner Genentech have announced that their candidate semorinemab is the first tau-targeting monoclonal antibody to show evidence of clinical activity in Alzheimer’s disease.
-
FDA panel votes to keep accelerated approval for Roche’s Tecentriq in breast cancer
Cryptically, Roche’s Genentech division simply said in a statement that it “looks forward to continuing to work with the FDA to determine next steps with regard to Tecentriq in this
-
FDA approves new self-injection administration for Xolair
The US Food and Drug Administration (FDA) has approved a new self-injection administration option for Novartis and Genentech’s immunoglobulin E (IgE) blocker Xolair.
More from news
Approximately 16 fully matching, plus 250 partially matching documents found.
Latest Intelligence
-
Are healthcare brands finally wising up to the power of creative-led communications?
And the list goes on. So it seems, encouragingly, that health and pharma brands – from Pfizer to Teva and Roche Genentech to Janssen – seem to finally be recognising the power of
-
20 for 2020 – Five pharma leaders to watch in 2020
Analysts think the deal could catapult Galapagos into the top tier of biopharma companies, joining the likes of Regeneron, Biogen and Roche’s Genentech unit, providing its pipeline delivers as hoped
-
Can protein degraders unlock ‘undruggable’ drug targets?
which adds to previous collaborations with Roche’s Genentech subsidiary, Pfizer, and also Merck &Co/MSD that committed $434m to the company shortly after it launched in 2013.
-
A snapshot of Microbiotica
There is also a $534m collaboration with Roche’s Genentech and an investment from Paris-based microbiome specialist VC Seventure.
-
Building European biotech firms to rival those of the US
of the US success stories of Amgen, Genentech and others.
More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.
Latest appointments
-
New hires at Abbott, Kite and Arrakis Therapeutics
Prior to BioMarin, Calderaro was the vice president of technical product management at Genentech.
-
New hires at Amgen, Eli Lilly and Zosano
Earlier in his career, Lo spent 13 years at Roche Group’s Genentech in roles of increasing responsibility in sales and marketing, ultimately serving as franchise head for endocrinology.
-
BMS appoints new commercial leader, Davies joins Eisai and more
He has also held a number of roles for Dendreon Corporation and Roche’s Genentech, where he worked on its Avastin franchise strategy.
-
Juno Therapeutics names Cindy Elkins as CIO
She joins the biopharma from Genentech, where she was VP of IT. ... Elkins most recently served as vice president, IT for the Americas at Genentech, where she led its US commercial technology integration following the firm's acquisition by Roche.
-
Revolution Medicines appoints Dr Stephen Kelsey
Prior to his time at Onkaido Therapeutics, Kelsey has served in several senior positions at Medivation, Generon and Genentech, where he held the role of vice president, haematology and oncology.
More from appointments
Approximately 1 fully matching, plus 28 partially matching documents found.
Latest from PMHub
-
September 2020: diversity and inclusion in clinical trials round-up
A recent study by Genentech aimed to get to the heart of the patient experience by interviewing over 2000 patients about their interactions with the healthcare system.
-
July 2020: diversity and inclusion in clinical trials round-up
Genentech make effort to boost diversity and inclusion in COVID-19 treatment studies. ... Genentech are also running the EMPACTA study, which will recruit patients from underserved communities.
-
Outsourcing in Clinical Trials 2020 Virtual Conference
trials. Meghan McKenzie, Genentech highlighted that disease pattern, clinical presentation and therapeutic response can vary dramatically with ethnicity and ancestral background. ... It was great to see that Genentech is trying to act based on insights
-
Augmented Reality in patient communication – don’t miss out!
Electronic Informed Consent Forms (e-ICFs) and Electronic Data Capture (EDC). In a recent well written article, Pierre Corin from Genentech discussed the drivers, advantages and possible challenges of using electronic ... References:. Pierre Corin,
-
It's time to change the conversation
Changing the conversation with patients. One of the earliest adopters of technology and social media to change the conversation with patients, was Genentech. ... Starting from the position of caring about the patient, Genentech created the Herceptin
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- My journey advancing the science in pulmonary hypertension
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
Spirit, an OPEN Health Company
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
